ask="83.55"
ask_size="2000"
average_daily_volume="602695"
bid="55.00"
bid_size="10000"
book_value="11.38"
change="-2.75"
change_from_200_day_moving_average="4.51"
change_from_50_day_moving_average="-4.14"
change_from_52_week_high="-23.30"
change_From_52_week_low="24.58"
change_in_percent="-3.72%"
close="71.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="74.33"
high_52_weeks="94.40"
last_trade_date="1/11/2017"
last_trade_price="71.10"
last_trade_size="26787"
last_trade_time="4:00pm"
low="69.77"
low_52_weeks="46.52"
market_capitalization="2.91B"
moving_average_200_day="66.59"
moving_average_50_day="75.24"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="73.60"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+6.78%"
percent_change_from_50_day_moving_average="-5.50%"
percent_change_from_52_week_high="-24.68%"
percent_change_from_52_week_low="+52.84%"
previous_close="73.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.49"
price_per_sales="23573.73"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="9.31"
stock_exchange="NMS"
symbol="RARE"
volume="574377"
weeks_range_52="46.52 - 94.40"
